Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy.
BRCA1/2
next-generation sequencing
ovarian cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
24 Oct 2019
24 Oct 2019
Historique:
received:
27
08
2019
revised:
01
10
2019
accepted:
21
10
2019
entrez:
27
10
2019
pubmed:
28
10
2019
medline:
28
10
2019
Statut:
epublish
Résumé
The PARP inhibitor olaparib has been approved in the maintenance setting of platinum-sensitive epithelial ovarian cancer patients with germline or somatic
Identifiants
pubmed: 31653094
pii: cancers11111641
doi: 10.3390/cancers11111641
pmc: PMC6896171
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
E.G.-R. received honoraria/advisory fee from Thermofisher Scientific, Roche, Novartis, AstraZeneca, M.B. received honoraria from Thermofisher Scientific, Roche, BMS, MSD, Biocartis.
Références
Sci Rep. 2014 Feb 07;4:4026
pubmed: 24504028
J Clin Med. 2019 Jan 18;8(1):null
pubmed: 30669267
J Clin Oncol. 2011 Aug 1;29(22):3008-15
pubmed: 21709188
Cancer Med. 2016 Jul;5(7):1640-6
pubmed: 27167707
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Nature. 2015 May 28;521(7553):489-94
pubmed: 26017449
Oncotarget. 2017 May 23;8(21):34858-34866
pubmed: 28422718
J Clin Oncol. 2010 Aug 1;28(22):3570-6
pubmed: 20606085
Oncotarget. 2016 Jan 12;7(2):1076-83
pubmed: 26745875
BMC Med Genomics. 2014 May 13;7:23
pubmed: 24885028
Eur J Hum Genet. 2016 Sep;24 Suppl 1:S10-8
pubmed: 27514839
PLoS Comput Biol. 2013 Apr;9(4):e1003031
pubmed: 23592973
Clin Cancer Res. 2014 Feb 1;20(3):764-75
pubmed: 24240112
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
pubmed: 25559415
Oncologist. 2012;17(7):956-62
pubmed: 22673632
Cancer. 2009 Mar 15;115(6):1234-44
pubmed: 19189349
Nat Biotechnol. 2012 May;30(5):434-9
pubmed: 22522955
J Mol Diagn. 2018 Sep;20(5):600-611
pubmed: 29936257
BMC Genomics. 2014 Jun 24;15:516
pubmed: 24962530
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
Cancer Res. 2008 Apr 15;68(8):2581-6
pubmed: 18413725
Nat Med. 2015 Aug;21(8):846-53
pubmed: 26248267
Semin Oncol. 2017 Jun;44(3):187-197
pubmed: 29248130
Eur J Cancer. 2016 Jul;61:137-45
pubmed: 27209246
J Clin Pathol. 2018 Sep;71(9):767-773
pubmed: 29535211
Ann Oncol. 2016 Aug;27(8):1449-55
pubmed: 27037296
Nature. 2012 Jan 18;481(7381):306-13
pubmed: 22258609